Accuray Seeks Stockholder Approval for $55M Recapitalization, Reverse Split, and Massive Dilution
ARAY sits 27% above its 52-week low of $0.22 on light trading volume (0.3× avg).
Summary
Accuray seeks stockholder approval for a $55M recapitalization, reverse stock split, and authorized share increase to avoid default and regain Nasdaq compliance.
Key Events · Financing and Capital Events · ARAY
-
Recapitalization Terms
Accuray will issue 55,000 shares of Series A Preferred Stock for $55 million: $15 million in cash and $40 million in debt conversion. The preferred stock converts into 110 million common shares at $0.50 per share.
-
Massive Dilution
Conversion of preferred stock and exercise of 15.3 million warrants at $0.01 per share would increase outstanding shares from approximately 119.4 million to over 244 million, diluting existing holders by more than 100%.
-
Reverse Stock Split
A reverse split of 1-for-15 to 1-for-40 is proposed to raise the stock price above $1.00 and regain Nasdaq compliance. The exact ratio will be determined by the Board.
-
Authorized Share Increase
Authorized common shares would increase from 200 million to 400 million to accommodate the conversion of preferred stock.
Analysis · ARAY · Industrial Applications And Services
Accuray is asking stockholders to approve a $55 million recapitalization that will convert $40 million of debt into preferred stock and raise $15 million in cash. The deal includes a reverse stock split of 1-for-15 to 1-for-40 to regain Nasdaq compliance, and an increase in authorized shares from 200 million to 400 million. If approved, the preferred stock converts into 110 million common shares at $0.50 per share, and warrants for 15.3 million shares at $0.01 per share are issued. This will cause substantial dilution to existing holders, but the alternative is a $15 million fee and continued debt burden. The special meeting is set for October 6, 2026.
At the time of this filing, ARAY was trading at $0.28 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $33.4M. The 52-week trading range was $0.22 to $2.10. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.